Obesity Surgery

, Volume 19, Issue 6, pp 788–790 | Cite as

Argon Plasma Coagulation and Gastric Bypass—A Novel Solution to Stomal Dilation

  • Ahmad AlyEmail author
Case Report


A patulous gastro-enterostomy after gastric bypass is a common cause of poor restriction and poor weight loss. Revisional surgery is an option but may be hazardous. This case report highlights the use of argon plasma coagulation by flexible endoscopy to reduce stomal size, improve restriction, and avoid revisional surgery.


Gastric bypass Argon plasma coagulation Dilated stoma Endoscopy 


  1. 1.
    Higa KD, Boone K, Nimeri A, et al. Gastric Bypass: increased restriction for poor weight loss. Surg Endosc. 2007;21:1922–23.CrossRefGoogle Scholar
  2. 2.
    Fobi MA, Lee H. The surgical technique of the Fobi-Pouch operation for obesity (the transected silastic vertical gastric bypass). Obes Surg. 1998;8(3):283–8. Jun.CrossRefGoogle Scholar
  3. 3.
    Schwartz RW, Stodel WE, Simpson WS, et al. Gastric bypass revision: Lessons learnt from 920 cases. Surgery. 1988;104:806–12.PubMedGoogle Scholar
  4. 4.
    De Csepel J, Nahouraii R, Gagner M. Laparoscopic gastric bypass as reoperative bariatric surgery for failed open restrictive procedures. Surg Endosc. 2001;15:393–97.CrossRefGoogle Scholar
  5. 5.
    Sharma P, Wani S, Weston Ap, et al. A randomised controlled trial of ablation of Barrett's oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results. Gut. 2006;55:1233–39.CrossRefGoogle Scholar
  6. 6.
    Snady H, Korsten MA, Waye JD. The relationship of bacteremia to the length of injection needle in endoscopic variceal sclerotherapy. Gastroinest Endosc. 1985;31:243–45.CrossRefGoogle Scholar
  7. 7.
    McGrew W, Goodin J, Stuck W. Fatal complication of endoscopic sclerotherapy: Serratia marcescens bacteremia with delayed esophageal perforation. Gastrointest Endosc. 1985;31:329–31.CrossRefGoogle Scholar
  8. 8.
    Bochna GS, Markin RS, Harty RF, et al. Development of squamous cell carcinoma of the esophagus after endoscopic variceal sclerotherapy. Am J Gastroenetrol. 1988;83:564–68.Google Scholar
  9. 9.
    Thompson CC, Slattery J, Bundga ME, et al. Peroral endoscopic reduction of dilated gastrojejunal anastomosis after Roux-en-Y gastric bypass: a possible new option for patients with weight gain. Surg Endosc. 2006;20:1744–48.CrossRefGoogle Scholar
  10. 10.
    Mahmood Z, McMahon BP, Arfin Q, et al. Endocinch therapy for gastro-oesophageal reflux disease: a one year prospective follow up. Gut. 2003;52:34–9.CrossRefGoogle Scholar
  11. 11.
    Mahmood Z, Messersmith R, Zaheer A, et al. Long-term five-year prospective follow-up of endocinch therapy for gastro-oesophageal reflux disease (Gord): Retention of plications are essential to control GORD. Gut. 2007;56(Supplement 2):A94.Google Scholar
  12. 12.
    Scheweitzer M. Endoscopic intraluminal suture plication of the gastric pouch and stoma in post operative Rouux-en-Y gastric bypass patients. J Laparoendosc Adv Surg Tech. 2004;14:223–26.CrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media, LLC 2008

Authors and Affiliations

  1. 1.Austin HospitalMelbourneAustralia

Personalised recommendations